Abstract
Cancer nanotechnology is an interdisciplinary area with broad applications. The basic rationale is that nanometre-sized particles, when linked with tumour-targeting ligands, can be used to target tumour antigens. It is difficult to target the abnormal cells in cancer by the conventional method of the drug delivery. Nanotechnology is probably the only method that can be used for site-specific action without causing the side effects. Different cancer detection techniques like Carbon Nanotubes (CNTs), nanorods and biosensors are available. This review paper gives an idea about the possible potential of nanotechnology in drug delivery, drug targeting and diagnosis of cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Bioinformatics Research and Applications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
